References
- Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. J Parasitol. 2009;39:1385–1394. doi:10.1016/j.ijpara.2009.04.003.
- Yap GS, Sher A. Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function. Immunobiol. 1999;201:240–247. doi:10.1016/S0171-2985(99)80064-3.
- Wang ZD, Liu HH, Ma ZX, Li Z, Yang Z. Toxoplasma gondii infection in immunocompromised patients: a systematic review and meta-analysis. Front Microbiol. 2017;8:389. doi:10.3389/fmicb.2017.00389.
- Robert-Gangneux F, Dardé ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012;25:264–296. doi:10.1128/CMR.05013-11.
- Robert-Gangneux F, Belaz S. Molecular diagnosis of toxoplasmosis in immunocompromised patients. Curr Opin Infect Dis. 2016;29:330–339. doi:10.1097/QCO.0000000000000275.
- Chew K, Wah MJ, Ambu S, Segarra I. Toxoplasma gondii: determination of the onset of chronic infection in mice and the in vitro reactivation of brain cysts. Exp Parasitol. 2012;130:22–25. doi:10.1016/j.exppara.2011.10.004.
- Shirbazou A, Delpisheh A, Tabatabaie F. et al. Serologic detection of anti-Toxoplasma gondii infection in diabetic patients. Life Sci J. 2013;10:313–315. doi:10.5812/ircmj.5303.
- Sibley LD, Boothroyd JC. Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature. 1992;359:382–385. doi:10.1038/359082a0.
- Liesenfeld O, Kosek J, Remington JS, Suzuki Y. Association of CD4+ T cell-dependent, interferon-gamma susceptibility of mice to per oral infection with Toxoplasma gondii. J Exp Med. 1996;184:597–607. doi:10.1084/jem.184.2.597.
- Levin SN, Lyons JL. Infections of the nervous system. Am J M. 2018;131:25–32. doi:10.1016/j.amjmed.2017.08.020.
- Bernstein C, Bernstein HCM, Payne CM, Beard SE, Schneider J. Bile salt activation of stress response promoters in Escherichia coli. Curr Microbiol. 1999;39:68–72. doi:10.1007/s002849900420.
- Nicoll S, Wright S, Malay W, Burns S, Buxton D. A mouse model of recrudescence of Toxoplasma gondi infection. J Med Microbiol. 1997;46:263–266. doi:10.1099/00222615-46-3-263.
- Deepak M1, Basavaprabhu A1, Soundarya M. Multiple intracerebral lesions in a young male. Afr Health Sci. 2015;15:1045–1048. doi:10.4314/ahs.v15i3.47.
- Djakovic D, Milenkovic T. Murine model of drug-induced reactivation of Toxoplasma gondii. Acta Protozool. 2001;40:99–106.
- Vreme CD, Pooley J, Hochrein H, Wu L, Shortman K. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. Immunol. 2000;164:2978–2986. doi:10.4049/jimmunol.164.6.2978.
- Drury RAB, Wallington EA. Carleton’s histological technique. 5th ed. Oxford: Oxford University Press; 1980.
- Karnovsky MJ. A formaldehyde-glutaraldehyde fixative of high osmolality for use in electron microscopy. J Cell Biol. 1965;27:137–138.
- Reynolds ES. The use of lead citrate at high pH as an electron-opaque opaque stain in electronmicroscopy. J Cell Biol. 1963;17:208–212. doi:10.1083/jcb.17.1.208.
- Frenkel JK. Pathophysiology of toxoplasmosis. Parasitol Today. 1988;4:238–273. PMID: 15463000. doi:10.1016/0169-4758(88)90018-x.
- Wong SY, Remington JS. Toxoplasmosis in the setting of AIDS. In: Samuel B, Thomas CM Jr., Dani B, eds.. Textbook of AIDS medicine. Baltimore: Williums & Wilkins; 1994:223–258.
- Ki-Man K, In-Uk C, Dae-Whan S, Young-Ha L. Cytokine and antibody responses of reactivated murine toxoplasmosis upon administration of dexamethasone. Korean J Parasitol. 2006;44:209–219. doi:10.3347/kjp.2006.44.3.209.
- Bruce MH. Steroids in autoimmune diseases. Aust Prescr. 1999;22:9–11. doi:10.18773/austprescr.1999.008.
- Bhadra R, Gigley JP, Khan IA. The CD8 T-cell road to immunotherapy of toxoplasmosis. Immunotherapy. 2011;3:789–801. doi:10.2217/imt.11.68.
- Hwang S, Khan IA. CD8+ T cell immunity in an encephalitis model of Toxoplasma gondii infection. Semin Immunopathol. 2015;37:271–279. doi:10.1007/s00281-015-0483-7.
- Silva LA, Brandão GP, Pinheiro BV, Vitor R. Immunosuppression with cyclophosphamide favors reinfection with recombinant Toxoplasma gondii strains. Parasite. 2012;19:249–257. doi:10.1051/parasite/2012193249.
- Puvanesuaran VR, Nowroji K, Sreenivasan S, SR N. Use of prednisolone to aid propagation of Toxoplasma gondii in mice. Eur Rev Med Pharmacol Sci. 2012;16:1028–1032.
- Elfadaly HA, Hassanain MA, Shaapan RM, Hassanain NA, Barakat AM. Steroids opportunist higher Toxoplasma gondii brain cysts in latent infected mice. Int J Zool Res. 2015;11:169–176. doi:10.3923/ijzr.2015.169.176.
- Mose J, Kamau D, Kagira J. et al. Development of neurological mouse model for toxoplasmosis using Toxoplasma gondii isolated from chicken in Kenya. Patholog Res Int. 2017;2017:4302459. doi:10.1155/2017/4302459.
- Takashima Y, Suzuki K, Xuan X, et al. Detection of the initial site of Toxoplasma gondii reactivation in brain tissue. Int J Parasitol. 2008;38:601–607. doi:10.1016/j.ijpara.2007.09.017.
- Boothroyd JC. Toxoplasma gondii 25 years and 25 major advances for the field. Int J Parasitol. 2009;39:935–946. doi:10.1016/j.ijpara.2009.02.003.
- Hulínská D, Sýkora J, Zástera M. Effect of cortisone on Toxoplasma gondii infection studied by electron microscopy. Folia Parasitol (Praha). 1990;37:207–212.
- Konradt C, Ueno N, Christian D. Endothelial cells are a replicative niche for entry of Toxoplasma gondii to the central nervous system. Nat Microbiol. 2016;1:16001. doi:10.1038/nmicrobiol.2016.1.
- Ferguson DJP, Grahamt DI, Hutchison WM. Pathological changes in the brains of mice infected with Toxoplasma gondii: a histological, immunocytochemical and ultrastructural study. Int J Exp Path. 1991;72:463–474.
- Hwang YS1, Shin JH1, Yang JP1, Jung BK, Lee SH, Shin EH. Characteristics of infection immunity regulated by Toxoplasma gondii to maintain chronic infection in the brain. Front Immunol. 2018;5:158. doi:10.3389/fimmu.2018.00158.
- El-Henawy A, Abdel-Razik A, Zakaria S, Elhammady D, Saudy N, Azab MS. Is toxoplasmosis a potential risk factor for liver cirrhosis? Asian Pac J Trop Med. 2015;8:784–791. doi:10.1016/j.apjtm.2015.09.003.
- Schmidt M, Sonneville R, Schnell D, et al. Clinical features and outcomes in patients with disseminated toxoplasmosis admitted to intensive care: a multicenter study. Clin Infect Dis. 2013;57:1535–1541. doi:10.1093/cid/cit557.
- Kendrick TS, Chin CK, Finlayson J. Disseminated toxoplasmosis with bone marrow involvement in a patient with acute lymphoblastic Leukaemia. Pathology. 2019;51:S42. doi:10.1016/j.pathol.2018.12.094.
- Paccoud O, Guitard J, Labopin M, Surgers L, Malard F. Battipaglia et al. Features of Toxoplasma gondii reactivation after allogeneic hematopoietic stem-cell transplantation in a high seroprevalence setting. Bone Marrow Transplant. 2019;21:1–7. doi:10.1038/s41409-019-0641-y.